STERIS plc (Ireland) (STE) Financials
STE Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 11.4 billion | 5.0 billion |
2023-09-30 | 11.3 billion | 5.1 billion |
2023-06-30 | 10.8 billion | 4.6 billion |
2023-03-31 | 10.8 billion | 4.7 billion |
STE Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 172.3 million | 15.3 million |
2023-09-30 | 62.8 million | 20.7 million |
2023-06-30 | 214.5 million | 11.6 million |
2023-03-31 | 144.4 million | 9.1 million |
STE Net Income
Date | Net Income |
---|---|
2023-12-31 | 140.9 million |
2023-09-30 | 116.3 million |
2023-06-30 | 123.8 million |
2023-03-31 | 187.0 million |
STE Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 195.6 million | - | 199.5 million |
2023-09-30 | 213.8 million | 3.4 billion | 196.2 million |
2023-06-30 | 208.6 million | 2.9 billion | 199.2 million |
2023-03-31 | 208.4 million | 3.0 billion | 195.5 million |
STE Shares Outstanding
STE Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 118.9 million | 25.9 million | 360.5 million | - |
2023-09-30 | 83.3 million | 27.0 million | 380.7 million | - |
2023-06-30 | 66.6 million | 25.5 million | 359.1 million | - |
2023-03-31 | 71.4 million | 26.4 million | 314.2 million | 21.7 million |
STE Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 1.4 billion | 793.1 million |
2023-09-30 | 1.3 billion | 748.8 million |
2023-06-30 | 1.3 billion | 711.1 million |
2023-03-31 | 1.4 billion | 796.8 million |
STE
List: Contenders
Price: $202.80
Dividend Yield: 0.01%
Forward Dividend Yield: 1.03%
Payout Ratio: 36.49%
Dividend Per Share: 2.08 USD
Earnings Per Share: 5.69 USD
P/E Ratio: 40.89
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 489871
Ebitda: 149.1 millionMarket Capitalization: 19.9 billion
Average Dividend Frequency: 4
Years Paying Dividends: 20
DGR3: 7.66%
DGR5: 7.98%
DGR10: 8.65%